Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab

Small-cell lung cancer (SCLC) is often associated with paraneoplastic syndromes. To assess the role of anti-neuronal autoantibodies (NAAs) as biomarkers of treatment outcome, we assessed NAAs in serial samples from SCLC patients treated with chemoimmunotherapy compared to chemotherapy alone. We eval...

詳細記述

保存先:
書誌詳細
出版年:Oncoimmunology
主要な著者: Hardy-Werbin, M., Arpí, O., Taus, A., Rocha, P., Joseph-Pietras, D., Nolan, L., Danson, S., Griffiths, R., Lopez-Botet, M., Rovira, A., Albanell, J., Ottensmeier, C. H., Arriola, E.
フォーマット: Artigo
言語:Inglês
出版事項: Taylor & Francis 2017
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5749672/
https://ncbi.nlm.nih.gov/pubmed/29308329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1395125
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料